Brilliant Thinking is Rare, But courage is in even shorter supply than genius. The challenge of future. #zerotoone

Market Sentiment & Investment Outlook: ✅ Bullish Sectors: Finance, Public Banks, Consumer Electronics, Renewable Energy. ⚠️ Cautious Sectors: Cement, Gas, Tyers. Monitor before investing.

Tomorrow promises to be a high-energy, action-packed day with a long lineup of results on the horizon.😎😎😎 Ambika Cotton Mills Ltd 🧵 Ahluwalia Contracts (India) Ltd 🏗️ AstraZeneca Pharma India Ltd 💊 Ashiana Housing Ltd 🏠 Andhra Sugars Ltd 🍬 Ami Organics Ltd 🧪 AWFIS Space Solutions Ltd 🏢 Bajaj Healthcare Ltd 💊 Bayer CropScience Ltd 🌱 Berger Paints India Ltd 🎨 Black Box Ltd 🖥️ Borosil Scientific Ltd 🔬 Birlasoft Ltd 💻 Century Enka Ltd 🏭 Cera Sanitaryware Ltd 🚽 CSL Finance Ltd 💰 Campus Activewear Ltd 👟 Consolidated Finvest & Holdings Ltd 📈 Ceinsys Tech Ltd 🛰️ Dolat Algotech Ltd 📊 Dalmia Bharat Sugar & Industries Ltd 🍚 Delton Cables Ltd 🔌 Deccan Cements Ltd 🏗️ Devayani International Ltd 🍽️ Electrotherm (India) Ltd 🔋 EIH Ltd 🏨 EPL Ltd 📦 EID Parry (India) Ltd 🌾 Faze Three Ltd 🛋️ Fermenta Biotech Ltd 🧪 GIC Housing Finance Ltd 🏡 Gensol Engineering Ltd ⚡ Gokul Agro Resources Ltd 🌾 Goodricke Group Ltd ☕ HEG Ltd 🔌 Huhtamaki India Ltd 📦 HVL Ltd 🎥 Hitachi Air Conditioning India Ltd ❄️ Igarashi Motors India Ltd 🚗 Indian Railway Catering & Tourism Corp. Ltd 🚆 Indo Borax & Chemicals Ltd ⚗️ Indo Tech Transformers Ltd 🔋 Indo Amines Ltd 🧪 Indo Count Industries Ltd 🛏️ IL&FS Engineering & Construction Co Ltd 🏗️ IIFL Capital Services Ltd 💵 Ircon International Ltd 🚆 Jindal Photo Ltd 📸 Jindal Poly Investment & Finance Company Ltd 💰 Jaykay Enterprises Ltd 🏭 Johnson Controls-Hitachi Air Condition. India Ltd ❄️ Juniper Hotels Ltd 🏨 Khadim India Ltd 👞 Kopran Ltd 💊 Kilitch Drugs (India) Ltd 💉 Keystone Realtors Ltd 🏢 Kuantum Papers Ltd 📄 Kolte Patil Developers Ltd 🏠 Kingfa Science & Technology (India) Ltd 🧪 Kriti Industries (India) Ltd 🏭 Lupin Ltd 💊 Mamata Machinery Ltd 🏭 Madras Fertilizers Ltd 🌿 Marksans Pharma Ltd 💊 MOIL Ltd ⛏️ Monte Carlo Fashions Ltd 👗 Magadh Sugar & Energy Ltd 🍚 Medicament Biotech Ltd 🧬 Maithan Alloys Ltd 🔩 Natco Pharma Ltd 💊 Nova Agritech Ltd 🌾 NBCC (India) Ltd 🏗️ NDR Auto Components Ltd 🚗 NBI Industrial Finance Company Ltd 💰 N R Agarwal Industries Ltd 📄 Optiemus Infracom Ltd 📱 One Point One Solutions Ltd 🖥️ Prince Pipes & Fittings Ltd 🚰 Prozone Realty Ltd 🏠 Praveg Ltd 🎭 Pearl Global Industries Ltd 👗 P&G Hygiene and Health Care Ltd 🛁 Pushkar Chemicals & Fertilizers Ltd 🧪 Raj Rayon Industries Ltd 🧵 Race Eco Chain Ltd 🌿 Ramky Infrastructure Ltd 🏗️ Ritco Logistics Ltd 🚛 Raghuvir Synthetics Ltd 👕 RHI Magnesita India Ltd 🔥 Suyog Telematics Ltd 📡 Shree Renuka Sugars Ltd 🍚 Satia Industries Ltd 📄 Salzer Electronics Ltd ⚡ Sequent Scientific Ltd 🧪 Schneider Electric Infrastructure Ltd ⚡ Steel Authority of India Ltd 🔩 Sunshield Chemicals Ltd 🧪 Shivalik Rasayan Ltd 🌱 Sirca Paints India Ltd 🎨 Sammaan Capital Ltd 💰 Taal Enterprises Ltd ✈️ Tata Investment Corporation Ltd 📈 Technocraft Industries (India) Ltd 🏭 Time Technoplast Ltd 📦 T.V. Today Network Ltd 📺 Tribhovandas Bhimji Zaveri Ltd 💎 Talbros Automotive Components Ltd 🚗 Tolins Tyres Ltd 🛞 Vertoz Ltd 📊 Vodafone Idea Ltd 📱 Windlas Biotech Ltd 💊 Wim Plast Ltd 🏭 Yasho Industries Ltd 🏭 Zee Media Corporation Ltd 📺

Would you like to know the key support, resistance, and crucial levels for all Nifty 50 stocks?

Patanjali Foods Ltd II Q3FY2025 🔥🔥🔥 💰 Revenue from Operations (Sales): ₹9,103.13 crore 🔼 QoQ Growth: +11.63% (₹8,154.19 crore in Q2 FY25) 🔼 YoY Growth: +15.08% (₹7,910.70 crore in Q3 FY24) 📈 Analysis: ✅ Robust revenue growth driven by higher FMCG & edible oil sales. ✅ Increased market penetration and higher demand for branded products contributed to growth. ✅ Strengthening distribution network and product expansion fueling topline growth. 🏦 Profit Before Tax (PBT): ₹491.25 crore 🔼 QoQ Growth: +17.73% (₹417.28 crore in Q2 FY25) 🔼 YoY Growth: +60.65% (₹305.78 crore in Q3 FY24) 📊 Analysis: ✅ Significant YoY profit growth due to better pricing strategy & operational efficiencies. ✅ Edible oil segment saw improved margins, contributing to overall PBT expansion. ✅ Cost control initiatives and strong sales mix supported profitability. 💵 Net Profit (PAT): ₹370.93 crore 🔼 QoQ Growth: +20.06% (₹308.97 crore in Q2 FY25) 🔼 YoY Growth: +71.30% (₹216.54 crore in Q3 FY24) 📈 Analysis: ✅ Strong PAT growth due to increased efficiency in supply chain & cost optimizations. ✅ Higher contribution from premium FMCG products resulted in better bottom-line performance. ✅ Sustained demand for health-based and natural products further supported profit growth. 📊 Earnings Per Share (EPS): ₹10.25 🔼 QoQ Growth: +20.06% (₹8.54 in Q2 FY25) 🔼 YoY Growth: +71.41% (₹5.98 in Q3 FY24) 📌 Analysis: ✅ EPS growth showcases strong earnings momentum and better shareholder returns. ✅ Continued brand investment and expansion leading to sustainable EPS growth. ✅ Higher profit margins ensuring stable earnings per share growth. 🔍 Verdict: BLOCKBUSTER 🔥🔥🔥 📈 QoQ Verdict: Strong Revenue & Profitability Growth. ✔ Revenue and PAT showed steady double-digit growth, reflecting robust demand. ✔ Cost efficiencies and pricing strategies boosted profitability. 🚀 YoY Verdict: Exceptional Performance Across All Segments ✔ Higher market penetration & pricing power led to revenue & profit growth. ✔ Edible oils & FMCG division seeing strong demand & margin expansion. 🎯 Overall Verdict: Record Growth in Revenue & Profits ✔ Patanjali Foods continues to dominate with solid revenue growth & margin expansion. ✔ Strategic diversification into high-growth FMCG & personal care products driving long-term success.

CRISIL Ltd II Q3 FY25 👍👍👍 💰 Revenue from Operations (Sales): ₹912.91 crore 🔼 QoQ Growth: +12.44% (₹811.84 crore in Q2 FY25) 🔽 YoY Growth: -0.53% (₹917.74 crore in Q3 FY24) 📈 Analysis: ✅ Revenue growth driven by increased demand in Ratings and Research segments. ✅ Slight YoY dip due to cyclical variations in consulting and research services. ✅ Strong business pipeline expected to support future revenue growth. 🏦 Profit Before Tax (PBT): ₹294.49 crore 🔼 QoQ Growth: +28.91% (₹228.53 crore in Q2 FY25) 🔼 YoY Growth: +5.62% (₹278.81 crore in Q3 FY24) 📊 Analysis: ✅ QoQ surge due to strong operational efficiencies and cost optimization. ✅ Steady YoY increase, demonstrating resilience despite economic fluctuations. ✅ Controlled expenses and improved pricing power helped maintain margins. 💵 Net Profit (PAT): ₹224.69 crore 🔼 QoQ Growth: +30.98% (₹171.55 crore in Q2 FY25) 🔼 YoY Growth: +6.93% (₹210.12 crore in Q3 FY24) 📈 Analysis: ✅ Improved PAT indicates robust profitability and efficient cost management. ✅ Strong cash flow generation and stable operating leverage. ✅ Business expansion and higher-margin service offerings contributed to bottom-line growth. 📊 Earnings Per Share (EPS): ₹30.72 🔼 QoQ Growth: +30.99% (₹23.46 in Q2 FY25) 🔼 YoY Growth: +6.89% (₹28.74 in Q3 FY24) 📌 Analysis: ✅ EPS growth reflects strong earnings momentum and improved financial health. ✅ Increased shareholder value driven by steady profit growth. ✅ Dividend payout remains strong, reinforcing investor confidence. 🔍 Verdict: Good 👍👍👍 📈 QoQ Verdict: Strong Growth in Profitability ✔ Profitability improved significantly due to operational efficiency. ✔ Cost control measures and higher-margin services helped sustain earnings. 🚀 YoY Verdict: Resilient Performance Despite Revenue Dip ✔ PAT and EPS continued to rise, reinforcing long-term business strength. ✔ Higher demand for ratings and risk analytics provided revenue stability. 🎯 Overall Verdict: Stable Revenue, Strong Profit Growth ✔ CRISIL continues to be a dominant player in ratings and research, showing resilience in a competitive market. ✔ Focus on ESG analytics, credit risk, and financial research will drive long-term growth.

ZIM Laboratories Ltd II Q3FY2025 👍 💰 Revenue from Operations (Sales): ₹96.33 crore 🔼 QoQ Growth: +4.54% (₹92.14 crore in Q2 FY25) 🔼 YoY Growth: +0.04% (₹96.29 crore in Q3 FY24) 📈 Analysis: ✅ Consistent revenue performance driven by strong demand for pharmaceutical formulations. ✅ Growth in key markets and stable order execution supported revenue. ✅ Higher contribution from export markets aiding long-term topline stability. 🏦 Profit Before Tax (PBT): ₹5.70 crore 🔼 QoQ Growth: +92.44% (₹2.96 crore in Q2 FY25) 🔽 YoY Decline: -18.71% (₹7.01 crore in Q3 FY24) 📊 Analysis: ✅ Sequential improvement in PBT due to better operational efficiencies. ❌ YoY decline due to higher raw material and employee costs. ✅ Strategic cost-cutting measures helped in profitability recovery. 💵 Net Profit (PAT): ₹4.00 crore 🔼 QoQ Growth: +68.02% (₹2.38 crore in Q2 FY25) 🔽 YoY Decline: -16.34% (₹4.78 crore in Q3 FY24) 📈 Analysis: ✅ Profitability improved QoQ, supported by cost efficiency measures. ✅ Steady revenue helped maintain earnings momentum. ❌ YoY decline attributed to increased operating expenses and higher finance costs. 📊 Earnings Per Share (EPS): ₹0.82 🔼 QoQ Growth: +67.34% (₹0.49 in Q2 FY25) 🔽 YoY Decline: -16.33% (₹0.98 in Q3 FY24) 📌 Analysis: ✅ EPS growth sequentially reflects better profitability. ✅ Slight YoY decline due to margin pressures. ✅ Long-term strategic growth initiatives expected to support future earnings expansion. 🔍 Verdict: MIXED PERFORMANCE 👍 📈 QoQ Verdict: Improvement in Profitability ✔ Revenue remained stable, while PBT & PAT improved significantly. ✔ Strategic cost control measures helped profitability rebound. 🚀 YoY Verdict: Profitability Under Pressure ✔ Higher costs impacted profit margins YoY, despite steady revenue. ✔ Need for continued cost optimizations to maintain margins. 🎯 Overall Verdict: Stable Revenue but Margin Pressures Exist ✔ ZIM Laboratories continues to expand but needs better cost management for stronger profitability.

Apollo Hospitals Enterprise Ltd II Q3FY2025👍👍👍 💰 Revenue from Operations (Sales): ₹5,527 crore 🔽 QoQ Decline: -1.11% (₹5,589 crore in Q2 FY25) 🔼 YoY Growth: +13.96% (₹4,850 crore in Q3 FY24) 📈 Analysis: ✅ Steady YoY revenue growth driven by increased patient footfall and expansion in specialty treatments. ✅ Continued momentum in Apollo HealthCo (pharmacy & digital healthcare business). ❌ QoQ revenue dip due to seasonality in hospital occupancy rates. 🏦 Profit Before Tax (PBT): ₹536 crore 🔽 QoQ Decline: -3.84% (₹557.40 crore in Q2 FY25) 🔼 YoY Growth: +47.60% (₹363.30 crore in Q3 FY24) 📊 Analysis: ✅ Significant YoY growth in PBT due to better operational efficiencies and cost controls. ✅ Strategic focus on high-margin specialty treatments improving profitability. ❌ QoQ decline due to higher operational costs in pharmacy and digital health business. 💵 Net Profit (PAT): ₹379.40 crore 🔽 QoQ Decline: -4.12% (₹395.70 crore in Q2 FY25) 🔼 YoY Growth: +49.13% (₹254.40 crore in Q3 FY24) 📈 Analysis: ✅ Strong YoY PAT growth, highlighting operational efficiency improvements. ✅ Expansion in hospital services and Apollo HealthCo segment contributing to overall profit increase. ❌ QoQ decline due to higher costs in digital healthcare expansion. 📊 Earnings Per Share (EPS): ₹25.89 🔽 QoQ Decline: -1.71% (₹26.34 in Q2 FY25) 🔼 YoY Growth: +51.72% (₹17.06 in Q3 FY24) 📌 Analysis: ✅ EPS growth showcases long-term financial strength and shareholder value. ✅ Improved profitability metrics driving better per-share earnings. ❌ QoQ EPS decline in line with the slight dip in PAT. 🔍 Verdict: GOOD 👍👍👍 📈 QoQ Verdict: Marginal Decline Due to Cost Pressures. ✔ Revenue and PAT declined slightly, but overall profitability remains strong. ✔ Investments in digital healthcare expansion led to temporary margin contraction. 🚀 YoY Verdict: Strong Growth Across All Segments ✔ Significant improvement in profitability, efficiency, and revenue. ✔ Expansion of specialty healthcare services & pharmacy segment driving long-term growth. 🎯 Overall Verdict: Stable Growth with Profitability Strength ✔ Apollo Hospitals continues to expand while maintaining strong financial health. ✔ Short-term cost increases in digital health are offset by long-term revenue potential.

@TjGiredar @CaVivekkhatri Good suggestion Thank you.

@Ugramveera Posted

@21danishh Posted

National Aluminium Company Ltd II Q3FY2025 🔥🔥🔥 💰 Revenue from Operations (Sales): ₹4,662.22 crore 🔼 QoQ Growth: +16.52% (₹4,001.48 crore in Q2 FY25) 🔼 YoY Growth: +39.23% (₹3,347.58 crore in Q3 FY24) 📈 Analysis: ✅ Strong revenue growth driven by increased aluminum production & higher sales volumes. ✅ Better pricing realization in the aluminum segment supported topline expansion. ✅ Demand for chemicals & industrial products remained stable, ensuring revenue consistency. 🏦 Profit Before Tax (PBT): ₹2,105.32 crore 🔼 QoQ Growth: +48.22% (₹1,420.34 crore in Q2 FY25) 🔼 YoY Growth: +223.68% (₹650.35 crore in Q3 FY24) 📊 Analysis: ✅ Exceptional YoY growth in PBT due to improved operational efficiencies & lower costs. ✅ Higher revenue contribution from aluminum & chemical divisions supported margin expansion. ✅ Cost optimizations & better pricing in core segments resulted in profitability surge. 💵 Net Profit (PAT): ₹1,566.32 crore 🔼 QoQ Growth: +49.74% (₹1,045.97 crore in Q2 FY25) 🔼 YoY Growth: +232.78% (₹470.61 crore in Q3 FY24) 📈 Analysis: ✅ Massive PAT growth supported by higher revenue & lower operating costs. ✅ Efficient cost management & operational discipline contributed to profit acceleration. ✅ Increased contribution from high-margin products improved earnings. 📊 Earnings Per Share (EPS): ₹8.53 🔼 QoQ Growth: +49.65% (₹5.70 in Q2 FY25) 🔼 YoY Growth: +233.59% (₹2.56 in Q3 FY24) 📌 Analysis: ✅ EPS growth signals strong shareholder value creation. ✅ Better profitability metrics & sustainable cash flow support future growth. ✅ Financially robust positioning enables consistent dividend payouts. 🔍 Verdict: BLOCKBUSTER 🔥🔥🔥 📈 QoQ Verdict: Strong Revenue & Profitability Growth ✔ Revenue & PAT surged sequentially, reflecting business expansion. ✔ Operational efficiencies & cost optimizations helped maintain margins. 🚀 YoY Verdict: Outstanding Performance Across All Metrics. ✔ Massive profitability surge due to higher demand & efficient cost control. ✔ Improved earnings from aluminum & chemical segments boosted bottom line. 🎯 Overall Verdict: Exceptional Growth in Revenue & Profits ✔ NALCO delivered a stellar quarter with robust revenue & profitability expansion. ✔ The company’s strategic focus on high-margin products continues to pay off.

@kumarsaurav9999 Posted

@kumarsaurav9999 Posted

@MadhuSu86288077 Posted

Tembo Global Industries Ltd II Q3FY2025 🔥🔥🔥 💰 Revenue from Operations (Sales): ₹160.45 crore 🔽 QoQ Growth: -1.47% (₹163.84 crore in Q2 FY25) 🔼 YoY Growth: +39.10% (₹115.37 crore in Q3 FY24) 📈 Analysis: ✅ Strong YoY revenue growth supported by increased demand for engineering products. ✅ Consistent execution of orders across domestic & export markets. ❌ QoQ decline due to temporary slowdown in project execution. 🏦 Profit Before Tax (PBT): ₹25.29 crore 🔼 QoQ Growth: +33.40% (₹18.96 crore in Q2 FY25) 🔼 YoY Growth: +325.02% (₹5.95 crore in Q3 FY24) 📊 Analysis: ✅ Massive YoY jump due to better operating margins & cost efficiencies. ✅ Operational improvements & strategic cost-cutting measures contributed to profit surge. ✅ Higher capacity utilization helped in maintaining profitability. 💵 Net Profit (PAT): ₹16.31 crore 🔼 QoQ Growth: +11.88% (₹14.58 crore in Q2 FY25) 🔼 YoY Growth: +266.68% (₹4.45 crore in Q3 FY24) 📈 Analysis: ✅ Substantial PAT growth driven by strong revenue execution & improved cost efficiency. ✅ Improved working capital management boosted cash flow & net profit. ✅ Strong demand in the construction & engineering sector supported growth. 📊 Earnings Per Share (EPS): ₹14.69 🔼 QoQ Growth: +11.89% (₹13.13 in Q2 FY25) 🔼 YoY Growth: +266.58% (₹4.01 in Q3 FY24) 📌 Analysis: ✅ Significant EPS growth indicates strong shareholder value creation. ✅ Improved profitability metrics driving better earnings per share. ✅ Company's strategic cost control and operational efficiency efforts reflected in earnings growth. 🔍 Verdict: BLOCKBUSTER 🔥🔥🔥 📈 QoQ Verdict: Strong Profitability Growth ✔ Significant improvement in profitability despite slight revenue decline. ✔ Cost efficiencies & better margins drove earnings higher. 🚀 YoY Verdict: Exceptional Revenue & Profit Surge ✔ Strong YoY growth across revenue, PBT, PAT & EPS. ✔ Higher demand for engineering products fueling topline growth. 🎯 Overall Verdict: Revenue Strength with Profitability Expansion ✔ Tembo Global Industries delivered an outstanding quarter with significant profit growth. ✔ Strategic focus on high-margin product segments driving earnings surge.

NCC Ltd II Q3FY2025 👍👍👍 💰 Revenue from Operations (Sales): ₹5,344.52 crore 🔼 QoQ Growth: +2.86% (₹5,195.98 crore in Q2 FY25) 🔽 YoY Growth: +1.60% (₹5,260.08 crore in Q3 FY24) 📈 Analysis: ✅ Stable revenue growth driven by project execution across road, rail, and building infrastructure. ✅ Higher order execution contributed to QoQ improvement. ❌ YoY growth remained muted due to delays in certain high-value projects. 🏦 Profit Before Tax (PBT): ₹259.92 crore 🔼 QoQ Growth: +3.94% (₹250.08 crore in Q2 FY25) 🔽 YoY Growth: -19.71% (₹323.72 crore in Q3 FY24) 📊 Analysis: ✅ Sequential profit growth due to operational efficiencies and cost management. ❌ YoY PBT decline due to increased raw material costs and higher finance expenses. ✅ Company remains focused on project efficiency and margin recovery in upcoming quarters. 💵 Net Profit (PAT): ₹205.86 crore 🔼 QoQ Growth: +17.75% (₹174.79 crore in Q2 FY25) 🔽 YoY Growth: -10.87% (₹230.96 crore in Q3 FY24) 📈 Analysis: ✅ Sequential PAT growth highlights cost control measures. ✅ Healthy profitability maintained despite cost headwinds. ❌ YoY PAT decline driven by margin contraction in key infrastructure projects. 📊 Earnings Per Share (EPS): ₹3.08 🔼 QoQ Growth: +18.46% (₹2.60 in Q2 FY25) 🔽 YoY Growth: -12.26% (₹3.51 in Q3 FY24) 📌 Analysis: ✅ Steady EPS growth sequentially, reflecting financial stability. ✅ Long-term project pipeline expected to support EPS recovery. ❌ Slight YoY decline due to lower profit margins. 🔍 Verdict: GOOD 👍👍👍 📈 QoQ Verdict: Profitability Improved, Revenue Stable ✔ Better execution and cost efficiencies led to higher PAT & EPS. ✔ New order inflows ensure continued revenue stability. 🚀 YoY Verdict: Profitability Declined Due to Cost Pressures. ✔ Revenue steady, but profitability impacted by higher costs. ✔ Company focused on improving operational efficiencies. 🎯 Overall Verdict: Stable Performance, Margins Need Recovery ✔ NCC Ltd continues to expand in key infrastructure projects while addressing cost challenges.